This bioRxiv preprint reports that stimulating the contralateral femoral nerve (M-only protocol, ~10% Mmax) robustly inhibits soleus motor units in 13 healthy adults: mean inhibition latency 29.9Β±3.4 ms and duration 44.5Β±4.2 ms (52/59 units retained). Contralateral responses exceeded ipsilateral by 8.5 ms latency (F(1,136)=432.98, P<0.001) and 8.7 ms duration (F(1,133)=191.81, P<0.001) in linear mixed-effects models, while latency was independent of firing rate in both conditions (pooled rΒ² β€ 0.03) .
The mechanistic claim rests on a Brian2 spiking-network library (96 contralateral simulations with vs. without V3-like commissural interneurons). Participant-specific MSE matching selected a V3-containing model for 100% of participants; for S4, Hedges' g was larger, indicating reduced residual precision. Crucially, this is indirect, model-based inference: the authors acknowledge V3 involvement in RI has never been demonstrated experimentally even in animals, and no human V3 identification exists . The falsification criterion is explicit: a non-V3 direct pathway fitting contralateral data equally well would weaken the claim β but no statistical significance test of model discrimination (e.g., likelihood-ratio or BIC) is reported, so "100%" could partly reflect parameter-sweep design rather than decisive evidence.
Overall verdict: a plausible and well-executed but indirect demonstration of crossed recurrent inhibition; the contralateral physiological effect is convincing, the V3 circuit attribution remains a testable conjecture pending animal or pharmacological (e.g., NMDA-blockade) verification.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.